Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
GSK Stock: A Value Trap or a Hidden Gem?
12:44pm, Thursday, 27'th Apr 2023
It's a complicated time for GSK (NYSE: GSK ), formerly known as GlaxoSmithKline. Shares of the U.K. pharmaceutical company have been volatile over the past month but have managed to stay in the green
GSK Beats on Q1 Earnings, Lags Sales, Reaffirms 2023 Outlook
12:11pm, Wednesday, 26'th Apr 2023
Though GSK's revenues benefit from strong growth across all segments, the declining COVID-19 antibody sales do not bode well. Management reaffirms its 2023 guidance.
Early ISA investors go for L&G, GSK and Fundsmith, while turning back on passive funds
11:23am, Wednesday, 26'th Apr 2023
Life insurers Legal & General Group PLC (LSE:LGEN) and Aviva PLC (LSE:AV.), banks such as Lloyds Banking Group PLC (LSE:LLOY) and funds including Terry Smith's Fundsmith Equity and income trusts C
Pharma Behemoths GSK, Roche Outplay Covid Declines To Beat Quarterly Calls
09:16am, Wednesday, 26'th Apr 2023
GSK and Roche both outplayed declining Covid-related sales in the first quarter to beat Wall Street's earnings expectations. The post Pharma Behemoths GSK, Roche Outplay Covid Declines To Beat Quarter
Was This Acquisition a Savvy Play by This Big Pharma Stock?
09:00am, Wednesday, 26'th Apr 2023
U.K.-based GSK is buying Canadian biotech Bellus Health for $2 billion. The purchase will include a promising drug candidate for treating chronic cough.
GSK (GSK) Tops Q1 Earnings Estimates
08:24am, Wednesday, 26'th Apr 2023
GSK (GSK) came out with quarterly earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $1.10 per share a year ago.
GSK Earnings Beat Expectations. Race for RSV Vaccine Leads Pipeline Hopes.
04:46am, Wednesday, 26'th Apr 2023
The pharmaceutical company is vying to bring the first shot for respiratory syncytial virus to market.
GSK first quarter profit dips to £1.49 billion but beat analyst forecasts
03:21am, Wednesday, 26'th Apr 2023
GSK PLC UK:GSK on Wednesday reported net profit and sales that beat expectations but declined on-year, and backed its guidance for the full year 2023.
GSK shares open higher as Q1 sales and profits beat expectations
03:13am, Wednesday, 26'th Apr 2023
Shares in GSK PLC (LSE:GSK, NYSE:GSK) opened higher after its first-quarter revenue and profits beat expectations with the outperformance driven by the success of its Shingrix shingles vaccine. It als
GSK and Standard Chartered earnings on Wednesday, plus US tech giants report
11:00am, Tuesday, 25'th Apr 2023
Standard Chartered PLC (LSE:STAN) will be the first of the FTSE 100 banks to report first-quarter results, having disappointed with earnings last time, but got a modest round of applause for better-t
GSK minds the gap as AstraZeneca streaks ahead
08:37am, Tuesday, 25'th Apr 2023
GSK's first quarter should see the UK pharma in decent shape operationally says analysts though the ongoing legal battle over Zantac compensation will remain the main influence on the share price unti
AstraZeneca results arrive with focus on drug trials, while GSK still faces Zantac overhang
01:23pm, Friday, 21'st Apr 2023
The FTSE 100's biggest company reports next week, AstraZeneca PLC (LSE:AZN) stepping up with a first-quarter trading update on Thursday, preceded by a day by its former close rival GSK PLC (LSE:GSK, N
GSK, Merck deals show appetite is ripe for biopharmaceutical M&A
04:56pm, Tuesday, 18'th Apr 2023
Biopharmaceutical companies are getting stock price lifts this week after two big deals in the space signal that M&A appetite is ripe. On Tuesday, GSK PLC (LSE:GSK, NYSE:GSK) revealed it has paid ar
Bellus Health Soars 98% As GSK Joins Buyout Bonanza With $2 Billion Deal
09:56am, Tuesday, 18'th Apr 2023
GSK added to a series of recent takeovers Tuesday with the $2 billion acquisition of Bellus Health. But BLU stock and GSK stock diverged.
Bellus Health's stock climbs on GSK deal, while Goldman Sachs is hurt by a revenue miss
08:31am, Tuesday, 18'th Apr 2023
Here are some of the biggest movers on Tuesday:
